Pfizer Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
32,408
36,122
23,290
17,850
19,992
18,833
Total Accounts Receivable
9,357
8,669
8,176
8,225
8,221
8,025
Inventories
6,166
5,663
7,513
6,783
7,578
7,508
Other Current Assets
8,313
7,248
4,825
6,091
5,351
15,560
Total Current Assets
56,244
57,702
43,804
38,949
41,141
49,926
Net Property, Plant & Equipment
12,397
11,762
13,766
13,318
13,865
13,385
Total Investments and Advances
16,406
17,518
15,999
7,116
7,015
2,767
Intangible Assets
81,904
77,235
88,598
107,097
104,693
88,622
Other Assets
3,596
3,513
3,420
3,323
3,227
2,798
Total Assets
172,101
169,274
167,381
171,615
171,797
159,422
ST Debt & Current Portion LT Debt
6,027
5,141
10,159
10,688
9,953
Accounts Payable
3,234
3,440
3,620
4,536
4,656
Income Tax Payable
730
574
418
437
477
Other Current Liabilities
13,375
12,476
15,202
15,454
15,341
Total Current Liabilities
23,366
21,631
29,399
31,115
30,427
Long-Term Debt
30,462
31,541
28,740
31,398
33,538
Provision for Risks & Charges
11,296
14,617
12,111
12,172
26,127
Deferred Taxes
24,036
23,437
25,083
28,941
2,045
Other Liabilities
4,767
4,882
5,257
6,337
6,149
Total Liabilities
95,481
97,652
102,384
111,775
100,141
Common Equity (Total)
76,274
71,272
64,694
59,520
71,287
Total Shareholders' Equity
76,307
71,301
64,720
59,544
71,308
Total Equity
76,620
71,622
64,998
59,840
71,656
Liabilities & Shareholders' Equity
172,101
169,274
167,382
171,615
171,797
Accumulated Minority Interest
313
321
278
296
348
Preferred Stock (Carrying Value)
33
29
26
24
21

About Pfizer

View Profile
Address
235 East 42nd Street
New York New York 10017
United States
Employees -
Website http://www.pfizer.com
Updated 07/08/2019
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare.